Study Finds Ozempic May Reduce Signs Of Fatty Liver Disease
A study in The New England Journal Of Medicine found that semaglutides, such as Ozempic and Wegovy, may help treat fatty liver disease, pointing to yet another potential use for these popular weight-loss drugs. What do you think?
'What about my other piece-of-shit organs?' Jane LeClair, Age Guesser
'My liver's gonna have abs!' Mike Reina, Collar Stitcher
'But will people's livers admit to using it?' Ron Tran, Unemployed
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
13 hours ago
- Newsweek
Research Shows This Action Can Increase Colon Cancer Survival Rate
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new study published by The New England Journal of Medicine on Sunday shows that adding an exercise program to recovery plans following treatment for colon cancer increased survival rates. Newsweek has reached out to the leaders of the study via email for information during non-working hours Sunday. Why It Matters Across the globe, colorectal cancer rates have skyrocketed, especially among millennials, with a 2024 study published by The Lancet showing those born in 1990 being two to three times more likely to have issues than those born in 1955. Colorectal cancer is the second most deadly and the third most prevalent in the world. In the United States, colorectal cancer is the fourth most common cancer for men and women, according to the Colorectal Cancer Alliance (CCA). Symptoms of colorectal cancers can include a change in bathroom habits, cramps, weight loss as well as blood in the stool, which can still look normal, according to These cancers can cause bleeding in the digestive tract and lead to anemia. Those who experience these symptoms should get tested by a medical professional. "Sometimes the first sign of colorectal cancer is a blood test showing a low red blood cell count," the American Cancer Society's website says. A stock photo shows people exercising at a gym. A stock photo shows people exercising at a gym. Getty What To Know The study followed patients in 55 medical centers for a three-year period following their initial treatment of surgery and chemotherapy. Over a 15-year period from 2009 to 2024, more than 800 patients were designated into either a health education group or exercise group. Researchers found that patients who began a three-year exercise program following chemotherapy had "significantly longer disease-free survival and findings consistent with longer overall survival." The study broke people up into two groups, a health-education program or a health education program in addition to a monitored exercise regime as part of the Colon Health and Lifelong Exercise Change. Both were done through the Canadian Cancer Trials Group. Of those who were a part of the exercise program, 80.3 percent saw a five-year disease-free survival, while 73.9 percent of the health-education group saw the same results. "Preclinical and observational studies suggest that exercise may improve cancer outcomes," the study said, adding that "definitive evidence" was lacking, hence the launch of this study. The exercise program participants received behavioral-support sessions as well as 12 in-person exercise sessions over two weeks for the first six months of the study. In the following six months, as part of phase two, patients continued to go to the support sessions either in person or virtually, along with their supervised exercise sessions. The last two years of the study required patients to go to in-person or remote support sessions, along with supervised exercise sessions, for those attending the support sessions in person. "Results support longer overall survival in the exercise group than in the health-education group," the study says. The study said that people who suffer from these diseases often have less quality of life and physical function issues, which the exercise program aims to help. "Interventions that improve both survival and quality of life in this patient population are needed," according to the study. However, even after treatment, recurrence happens 20 to 40 percent of patients, but the exercise program can cut that risk down, the new study shows. What People Are Saying Dr. Christopher Booth, a co-chair of the international study and a medical oncologist at Kingston Health Sciences Centre in Kingston, Ontario, told The Candian Press: "It's the first clinical trial in the world asking whether exercise can improve cancer survival. And in fact, the results were we had a cancer drug with this amount of benefit, it would cost between $100,000 and $200,000 per year (and) it would be celebrated in all the major guidelines across oncology societies worldwide." What Happens Next? Even after treatment, recurrence happens 20 to 40 percent of patients, but an exercise program can cut the risk down, according to the new study. Those who have received treatment for colorectal cancer should talk to their doctor before starting any exercise programs.
Yahoo
a day ago
- Yahoo
Most common causes of cavities in the teeth — and how to prevent them
Cavities are incredibly common, affecting 90% of adults between the ages of 19 and 64 — but they are often preventable. Also known as "dental caries," cavities are damaged areas in the hard parts of the teeth caused by tooth decay, according to Mayo Clinic. These areas become tiny openings or holes that can lead to toothaches, infections and even tooth loss. When a cavity is just starting, you may not have any symptoms at all. That's why it's important to be checked regularly at a dentist, says the Centers for Disease Control and Prevention (CDC). Even if your mouth feels fine, a professional may be able to pick up on smaller signals before the decay grows. Is Ozempic Ruining Your Teeth? What To Know About Impact On Dental Health Read On The Fox News App Once the decay gets larger, there may be symptoms like toothaches, sharp pains when eating, visible holes in the teeth, staining on the surface of a tooth or pain when biting. Dental plaque forming in the mouth is what leads to tooth decay, the process that creates cavities. Plaque forms when bacteria in the mouth mixes with "sugary or starchy food" like milk, juice, bread and pasta, according to Cleveland Clinic. Fluoride Exposure Linked To 'Detrimental Effects' On Health Of Pregnant Women, Infants If those sugars and starches are not removed from the teeth through healthy habits, like regular flossing and brushing after meals, bacteria begin feeding on them, the above source states. The acids from bacteria strip away tooth enamel, leaving tiny openings that mark the beginning stages of a cavity. Bacteria and acid can enter through these holes and reach the vulnerable inner parts of the teeth, causing pain and more severe problems. Fox News Digital previously spoke to Dr. Ricky Marshall about the impact of stomach acid and saliva production on dental health. "The amount of acid coming up and contacting the teeth will absolutely contribute to increased tooth decay," said Marshall, who is the owner of Stratland Dental in Glendale, Arizona, and a dentist at Wolff Family Dentistry & Orthodontics in Queen Creek, Arizona. "A combination of dry mouth and increased stomach acid can be detrimental to teeth," he said. Brush, Floss, Mouthwash: Dentists Reveal What They Believe Is The Correct Order Dry mouth, linked to causes like snoring and potentially certain medications, can increase the risk of tooth decay due to reduced saliva production. "Your saliva clears away the acid and helps to repair the enamel," the CDC states on its website. "If the repair isn't fast enough, bacteria get inside your tooth and make cavities." Cleveland Clinic recommends brushing your teeth with a soft-bristled brush twice a day, and ideally after every meal. Click Here To Sign Up For Our Health Newsletter Experts also recommend cutting back on sugary, starchy foods and drinks. As mentioned above, these can mix with bacteria and promote the buildup of dental plaque. For more Health articles, visit "You should visit your dentist every year, especially to find any cavities," the CDC advises. For small cavities, your dentist may recommend using fluoride or other products. Large cavities may require fillings or even root article source: Most common causes of cavities in the teeth — and how to prevent them
CNBC
a day ago
- CNBC
Hims to cut 4% of workforce amid ban on weight-loss drug copies
NEW YORK, May 30 (Reuters) - Telehealth platform Hims & Hers (HIMS.N), opens new tab will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on manufacturing mass copies of the weight-loss drug Wegovy. A U.S. Food and Drug Administration ban on compounded copies of Wegovy, made by Novo Nordisk ( opens new tab, took effect on May 22. Hims shares have since dropped 14%. The company confirmed the job cuts in a statement on Friday. On Saturday, it said that the reductions were not related to the compounding ban. Hims did not provide details about the roles that were cut, but said they were implemented across teams. "These changes are focused on sharpening how we execute, without affecting our priorities or the specialties we're committed to," a company spokesperson said regarding the layoffs. Hims still plans to hire for roles related to its long-term growth strategy. The company recently announced an agreement with Novo to help patients access brand-name Wegovy. It plans to enter the market for low testosterone and menopause treatments and is looking at offerings to improve longevity and sleep. Bloomberg News reported the job cuts earlier on Friday. In 2022, the FDA declared a shortage of Wegovy, which has been shown to help patients lose around 15% of their body weight. That declaration allowed compounding pharmacies to produce the drug to meet demand. Hims began offering copies of Wegovy in 2024, often at far lower prices than the brand-name version. That boosted subscriptions to the Hims telehealth platform, with revenue up 111% on a yearly basis during the first quarter of 2025. Wegovy copies and similar GLP-1 weight-loss drugs accounted for $200 million of the company's $1.5 billion revenue in 2024. The FDA in February said Wegovy was no longer in shortage and ended the exception that allowed sale of mass compounded copies of the patented medication. Hims and its rivals have pivoted to what they say are customized copies of Wegovy that should not be subject to the FDA decision, featuring smaller doses or allowing for a more individualized plan for increasing dosage than offered by Novo. But analysts said that personalization strategy may not be enough to stave off new legal challenges from Novo. "It remains to be seen whether HIMS method of personalization (titration and dosage) is enough to meet the compounding clinical exemption need," said Jailendra Singh, a healthcare analyst at Truist.
